6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID)
S. Nathan, C. Albera, R. du Bois, W. Bradford, U. Costabel, T. King, P. Noble, S. Sahn, D. Valeyre (Falls Church, Brisbane, San Francisco, Durham, Charleston, United States Of America; Turin, Italy; London, United Kingdom; Essen, Germany; Paris, France)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Session: Diffuse parenchymal lung disease III
Session type: Thematic Poster Session
Number: 3656
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Nathan, C. Albera, R. du Bois, W. Bradford, U. Costabel, T. King, P. Noble, S. Sahn, D. Valeyre (Falls Church, Brisbane, San Francisco, Durham, Charleston, United States Of America; Turin, Italy; London, United Kingdom; Essen, Germany; Paris, France). 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID). Eur Respir J 2012; 40: Suppl. 56, 3656
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: